. Biomarkers for following Alzheimer's disease progression. Amyloid 11C-PIB imaging in a multi-tracer paradigm with 11C-d-deprenyl and 18F-FDG studied in preclinial and clinical AD. Human Amyloid Imaging 2011 Meeting Abstracts. 2011 Jan 15;

Abstract:

Recent progress in molecular imaging provides new knowledge for the understanding of the time course of early pathological disease processes in Alzheimer's disease (AD). We have observed that 11C-PIB PET can detect increasing accumulation of fibrillar As in the brains of MCI patients at follow up while more stable levels of fibrillar As are measured at clinical AD. For understanding of the pathological impact of different forms of As in brain there is a need for development of PET ligands detecting smaller forms of As, oligomeric forms in brain but also to understand how synaptic activity and inflammatory processes are related to As pathology. PET fibrillar As imaging together with CSF biomarkers are promising biomarkers for early recognition of subjects at risk for AD. In a current longitudinal study, we are enrolling both presymptomatic and symptomatic members of different Swedish families harboring mutations in the PS1 gene and the 'Swedish' and the 'Arctic' APP gene mutations. We use the PET tracers 11C-PIB for measuring fibrillar As load, 18F-FDG to investigate cerebral glucose metabolism, and 11C-d-Deprenyl to visualize astrocytosis as a component of neuroinflammatory processes. The subjects also undergo neuropsychological testing, MRI scan and assays of CSF biomarkers. Cohorts of AD and MCI patients are studied with the same protocol. Data are analyzed with use of principle component analysis method. Data so far obtained indicate that increases in As deposition as well as astrocytosis occur early in brain at presymptomatic stages of AD but the time course of changes as well as brain regions afflicted differ between PET tracers reflecting the complexity of AD pathology. These studies are important for future drug trials in presymptomatic AD. References: Nordberg et al. Nature Reviews Neurology 2010; Kadir et al. Neurobiol Aging 2010; Scholl et al. 2009; Kadir, Nordberg. J Nucl Med 2010; 51: 1418-1430; Kadir Marutle et al. Brain in press.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

This paper appears in the following:

News

  1. Miami: HAI Amyloid Imaging Conference Abstracts